Journal Detail Information

1

Cite

Share

Comparison of different chemiluminecence immunoassay analyzers for determination of serum thyroid stimulating hormone in patients with suspicious subclinical hypothyroidism

Tingting WANG ; Fengling SHAN ; Hankui LU

Chinese Journal of Nuclear Medicine and Molecular Imaging.2017;37(6):342-345. doi:10.3760/cma.j.issn.2095-2848.2017.06.005

Objective To evaluate the differences of serum TSH of suspicious subclinical hypothyroidism determined by four automatic biochemical analyzers and the impact on clinical diagnosis and treatment.Methods Taking results of Roche Cobas e601 laboratory test as a reference, 103 serum samples with TSH 2.50-10.00 mU/L(90 with TSH≥4.27 mU/L) and normal FT3, FT4 were selected.Four different automatic biochemical analyzers (Cobas e601, Immulite2000, Centaur XP, I2000) were used to measure TSH of the serum samples at the same time.Wilcoxon signed rank test, Spearman correlation analysis were used for data analysis.Results TSH (M(P25, P75)) measured by 4 methods were 5.20(4.73, 6.40), 2.95(2.59, 3.48), 3.30(2.94, 4.15) and 4.10(3.43, 4.75) mU/L, which varied significantly from one assay to another (z values:-8.78,-8.41,-7.64,-8.09,-8.50, all P<0.05).The correlations between methods were of great differences (rs ranged from 0.45 to 0.92).Significant differences existed in each other for subclinical hypothyroidism diagnosis based on TSH cutoff respectively.Conclusion Results from different automatic immunoassay analyzers in patients with TSH of 2.50-10.00 mU/L varied widely, hence, it is indeterminate to diagnose subclinical hypothyroidism only relies on a single serum TSH test.

2

Cite

Share

18F-FDG uptake and clearance in the amygdala and hippocampus in patients with first-episode depression

Yan ZHU ; Yuefeng LI ; Tian ZHAO ; Liang ZHAO ; Ruigen YIN ; Dongqing WANG

Chinese Journal of Nuclear Medicine and Molecular Imaging.2017;37(12):758-762. doi:10.3760/cma.j.issn.2095-2848.2017.12.002

Objective To observe the dynamic changes of 18F-FDG uptake and clearance in the amygdala and hippocampus in patients with first-episode depression (FED),and explore the neurobiology mechanism of FED.Methods i8 F-FDG PET/CT imaging was performed on 35 patients with FED and 35 healthy volunteers from January 2014 to January 2016.SUV in the amygdala and hippocampus at different time points were collected.The clearance rates were calculated and the difference between patients and healthy volunteers were compared by two-sample t test.Results The FDG uptake in the left amygdala of patients reached the peak earlier compared with that in the healthy group,with the SUVmax of 12.94±2.03 at 25 min and 10.50±1.79 at 40 min,respectively.FDG uptake in the left amygdala at 10,25,40,55,70,85 min between the 2 groups were significantly different (t values:12.92,8.65,6.99,12.34,28.87,13.87;all P＜ 0.05).The clearance rate in the left amygdala of patients at different time interval was increased compared with that of the healthy group(40-55 min:t=32.53;56-70 min:t=32.73;71-85 min:t=11.10;all P＜ 0.05).Compared with the healthy group,FDG uptake in the left hippocampus of patients was decreased significantly at 10,25,40,55,85 min (t values:2.70,7.75,7.78,8.81,7.00;all P＜0.05) for FDG uptake,and the clearance rate was also decreased significantly at different time interval(40-55 min:t =6.02;56-70 min:t=62.15;71-85 min:t=37.39;all P＜0.05).Differences of metabolic changes in the right amygdala and the right hippocampus were not significant.Conclusions 18F-FDG metabolism in the amygdala and hippocampus of patients with FED may be abnormal,which is characterized by earlier peak uptake and quicker clearance in the left amygdala while lower uptake and slower clearance in the left hippocampus.

3

Cite

Share

Progress of nanoprobes for cancer diagnosis and treatment

Wenting SHANG ; Jie TIAN

Chinese Journal of Nuclear Medicine and Molecular Imaging.2017;37(11):726-729. doi:10.3760/cma.j.issn.2095-2848.2017.11.014

Nanoprobes are new contrast agents used in medical imaging. Nanomaterials have con-trollable size and surface charge, high porosity, large specific surface area, and they are easily to be modi-fied. Due to the advantages of excellent imaging effect, nanoprobes have a variety prospect of clinical appli-cation, such as tumor imaging, angiography, drug delivery. This review summarizes nanoprobes researches on cancer diagnosis and treatment in recent years.

4

Cite

Share

Prognostic value of 18 F-FDG PET/CT in patients with limited-stage small cell lung cancer

Chongyang DING ; Zhe GUO ; Yulin WU ; Yangyang LI ; Tiannyu LI

Chinese Journal of Nuclear Medicine and Molecular Imaging.2017;37(11):694-699. doi:10.3760/cma.j.issn.2095-2848.2017.11.005

Objective To investigated the prognostic value of 18 F-FDG PET/CT in patients with limited-stage small cell lung cancer (LS-SCLC). Methods Sixty-six patients (58 males, 8 females;median age 65 years) with LS-SCLC who underwent pretreatment 18 F-FDG PET/CT from April 2009 to December 2015 were included in this retrospective study. The relations between the SUVmax , the sum of MTV ( MTVsum ) , the sum of TLG ( TLGsum ) and clinical factors were analyzed. ROC curve was plotted to estimate the most discrimination threshold ( cutoff point) for each parameter to maximize the sensitivity and specifici-ty in predicting the progression or recurrence. Kaplan-Meier method and log-rank test were used to perform univariate survival analysis and Cox proportional hazards model for multivariate analysis. Results The SUVmax, MTVsum and TLGsum of 66 patients were 10.57±3.27, 38.71(2.89, 221.68) cm3 and 267.04 (1167, 1684.13), respectively. SUVmax, MTVsum and TLGsum were all associated with hydrothorax, the maximum diameter of tumor, clinical stage and LDH. MTVsum and TLGsum were also associated with tumor type and NSE. During the median 33 months of follow-up, 4 patients were lost to follow-up, 43 patients were progressive or recurrent with the median PFS of 12.30 months, and 38 patients died with the median OS of 15.75 months. The optimal cutoff point of SUVmax, MTVsum and TLGsum were 10.08, 16.18 cm3, 209.14, re-spectively. Univariate analysis showed that hydrothorax, the maximum diameter of tumor, clinical stage, NSE, LDH, surgery, MTVsum and TLGsum were all associated with PFS and OS. SUVmax was associated with PFS, but not with OS. Multivariate analysis demonstrated that NSE, LDH, MTVsum and TLGsum were the in-dependent predictors of PFS ( HR:3.83, 4.46, 9.26, 3.87, all P<0.05) , and LDH, MTVsum were also the independent predictors of OS ( HR:2.77, 6.83, both P<0.05) . However, SUVmax was not the independent predictor of PFS(HR=1.47, P>0.05). Conclusions 18F-FDG PET/CT can predict the prognosis of pa-tients with LS-SCLC. SUVmax is correlated with PFS, MTVsum and TLGsum are independent predictors of PFS, and MTVsum is also an independent predictor of OS.

5

Cite

Share

A novel integrinαvβ3-targeted isoDGR probe for SPECT/CT imaging of glioma

Haitao ZHAO ; Luoping ZHAI ; Hannan GAO ; Fan WANG ; Jun ZHAO ; Jiyun SHI

Chinese Journal of Nuclear Medicine and Molecular Imaging.2017;37(11):689-693. doi:10.3760/cma.j.issn.2095-2848.2017.11.004

Objective To prepare 99 Tcm-HYNIC-c( isoDGRKy) as a SPECT/CT imaging molecu-lar probe targeting integrin αvβ3 , and evaluate its biodistribution and feasibility on SPECT/CT imaging for integrinαvβ3-positive tumor in U87MG human glioma xenograft mouse models. Methods The bifunctional chelator HYNIC was conjugated to c( isoDGRKy) , and tricine and TPPTS were used as coligands for 99 Tcm labeling to prepare 99 Tcm-HYNIC-c( isoDGRKy) . The radiochemical purity and stability of the product were measured. The expression of integrin αvβ3 and binding affinity ( half maximal inhibitory concentration, IC50 ) of c ( isoDGRKy ) was detected in U87MG cells by cell experiments in vitro. Biodistribution and SPECT/CT imaging of 99 Tcm-HYNIC-c( isoDGRKy) including blocking experiments were performed respec-tively in nude mice bearing U87MG human glioma xenografts. Results The radiochemical purity of 99 Tcm-HYNIC-c( isoDGRKy) was over 99%, and was still over 99% after 4 h incubation in saline at room temper-ature. Flow cytometry assay showed that U87MG cells were integrinαvβ3-positive ( expressive rate:70%) . The IC50 of c(isoDGRKy) was 6.67×10-8 mol/L. Biodistribution results showed 99Tcm-HYNIC-c(isoDGRKy) with a rapid clearance from blood was excreted mainly via the kidneys. The 99 Tcm-HYNIC-c( isoDGRKy) uptake values in U87MG tumors were (7.31±1.42) and (1.09±0.11) %ID/g at 15 and 45 min post-injection re-spectively, and tumor-to-muscle ratio reached 5.01±1.47 at 15 min post-injection. The tumors were clearlyvisualized with low background from 0.5 to 1 h post-injection in tumor bearing mice. In the blocking experi-ment, the tumor was barely visualized after co-injection of excess cold c(RGDfK) peptide with 99Tcm-HYNIC-c(isoDGRKy). Conclusions 99Tcm-HYNIC-c(isoDGRKy) may be easily and steadily prepared. It may be a RGD-like promising SPECT/CT imaging probe for integrinαvβ3-positive tumor.

6

Cite

Share

Dual-modality imaging-guided sonodynamic therapy with DVDMS-Mn-loaded liposomes

jun Mei ZHOU ; Fei YAN ; Zhen GAN ; Hao WU ; Hongmei LIU

Chinese Journal of Nuclear Medicine and Molecular Imaging.2017;37(11):685-688. doi:10.3760/cma.j.issn.2095-2848.2017.11.003

Objective To fabricate DVDMS-Mn-LPs and evaluate its potential on fluorescence mo-lecular imaging, MRI and sonodynamic therapy ( SDT) . Methods DVDMS was used to chelate with Mn2+, and then encapsulated into nanoliposomes by a typical thin-film rehydration method to fabricate DVDMS-Mn-LPs. The particle morphology, average diameter, zeta potential, encapsulation efficiencies and Mn2+content were determined. Fluorescence molecular imaging was performed on different concentrations of DVDMS-Mn-LPs (0, 40, 80, 120, 160 μg/ml) with the small animal fluorescence imaging system. T1WI was per-formed with 3.0 T MR. The SDT effect of DVDMS-Mn-LPs was verified by CCK8 assay among the following groups:control group, ultrasound group ( experimental group 1, EG1) , DVDMS-Mn-LPs group ( EG2) and DVDMS-Mn-LPs + ultrasound group ( EG3) . One-way analysis of variance and the least significant differ-ence t test were used to analyze the data. Results DVDMS-Mn-LPs exhibited a well-defined spherical mor-phology and homogeneous distribution. The encapsulation efficiency was (65.56±1.47)%. ICP-AES meas-urement revealed that the chelation of Mn2+ with DVDMS occurred at a molar ratio of 1. 6:1. The fluores-cence intensities progressively increased with the elevated concentrations of DVDMS-Mn-LPs. The r1 value for DVDMS-Mn-LPs was 23.74 mmol·L-1·s-1. The cell viabilities of EG3 was (54.82±8.55)%, which were significantly lower than those of EG2 and EG1 ((86.54±2.67)% and (83.76±6.48)%;F=6011, t values: -8.35, -9.15, all P<0.001). Conclusion DVDMS-Mn-LPs is successfully fabricated and has good potential on fluorescence molecular imaging, MRI and SDT, which provides a promising imaging-guided modality for glioma treatment in vivo.

7

Cite

Share

In vivo characterization of a novel Cerasome based multi-modality imaging probe

Di FAN ; ping Luo ZHAI ; Hannan GAO ; Fan WANG ; Lin AI ; Jiyun SHI

Chinese Journal of Nuclear Medicine and Molecular Imaging.2017;37(11):680-684. doi:10.3760/cma.j.issn.2095-2848.2017.11.002

Objective To prepare a novel dual-modality imaging probe based on Cerasome nano-materials, and evaluate its in vivo biodistribution and pharmacokinetic properties. Methods ICG encapsu-lated Cerasome was modified with chelating agent DOTA for 111 In-labeling. Normal mice firstly were used for in vivo studies. Animals were sacrificed at different time points after tail vein administration, blood samples were taken and the organs of interest were captured to evaluate the pharmacokinetic properties and in vivo biodistribution of 111 In-ICG-DPDCs. The subcutaneous Lewis lung carcinoma ( LLC ) tumor model in C57BL/6 mouse was established. The tumor-bearing mice were subjected to optical imaging in small animal IVIS and SPECT imaging in small animal nanoScanSPECT/CT system for tumor uptake of 111 In-ICG-DPDCs. Results The size of the nanoparticle probe was about 90 nm, and the 111 In-labeling was successfully per-formed with 99.93% radiochemical purity after purification. 111 In-ICG-DPDCs showed excellent in vitro sta-bility with 97.10% radiochemical purity at 48 h post-purification. In vivo blood clearance experiments showed that 111 In-ICG-DPDCs had a relative long blood circulation time with the fast and slow phase half-lives of 40 and 132.7 min. 111In-ICG-DPDCs accumulated mainly in the liver and spleen, with long retention time. NanoScanSPECT/CT imaging showed that LLC tumors were significantly visualized at 4 h post-injection, and the other major accumulated organs were the liver and spleen, which were consistent with the results of biodistribution. Optical imaging showed significant uptake of the nanoparticle probe in the tumor, confirming the SPECT imaging results. Conclusion The Cerasome based probe designed could be used for tumor SPECT and optical dual-modality imaging, and has potential for therapeutic use.

8

Cite

Share

Advances in CT-guided 125 I seed implantation on residual or relapsing metastatic cervical and medi- astinal lymph nodes

Daoqin ZHANG ; Zhongwei LYU

Chinese Journal of Nuclear Medicine and Molecular Imaging.2017;37(11):738-742. doi:10.3760/cma.j.issn.2095-2848.2017.11.017

Cervical and mediastinal lymph nodes ( CMLN) are usually close to some important ves-sels, nerves and organs, which brings much difficult for surgical and radiotherapy. CT-guided 125 I seed im-plantation is becoming an effective, safe and reliable treatment. CT could be used to observe the distribution of seeds, complication and therapeutic effect after the implantation. This paper focuses on the advances of CT-guided 125 I seed implantation on residual or relapsing metastatic CMLN.

9

Cite

Share

Recent progress of 89 Zr tracers for PET imaging

Siyuan CHENG ; Hao HONG ; Xiaohua ZHU

Chinese Journal of Nuclear Medicine and Molecular Imaging.2017;37(11):733-737. doi:10.3760/cma.j.issn.2095-2848.2017.11.016

89Zr is a positron-emitting metal with a long half-life (78.4 h) which is compatible to the labeling of slow-accumulating bioactive vectors. Many researchers have adopted 89 Zr for medical research. DFO is the most prevalent chelator used to link 89 Zr with bioactive vectors to synthesize stable PET agents, which gives high-resolution PET images with exceptional T/NT ratio. This review describes five methods based on DFO to synthesize 89 Zr-based PET agents, among which isothiocyanate ( Df-Bz-NCS) and N-succi-nyl-DFO ( N-suc-DFO) have been used in clinical studies. The targeting bioactive vectors labeled by 89 Zr for PET imaging include antibodies (monoclonal antibodies and their derivatives), polypeptides (RGD pep-tides), proteins (transferrin, albumin, etc.), bioengineering structures (nanoparticles, liposomes, micro-spheres, etc.), cells (stem cells, immune cell subsets) and so on. The application of 89Zr PET in drug de-velopment, cell tracking and tumor imaging has become increasingly prominent.

10

Cite

Share

Research progress on the radio-synthesis of PET probes in microfluidic chips

Ming LEI ; ming Guang XU ; Jianzhang PAN ; Hong ZHANG

Chinese Journal of Nuclear Medicine and Molecular Imaging.2017;37(11):730-732. doi:10.3760/cma.j.issn.2095-2848.2017.11.015

Radio-synthesis of PET tracers in microfluidic chip system for imaging research could fa-cilitate synthesis and screening of radiotracer. Moreover, modular and multi-functional microfluidic chip syn-thesis system could realize the combination of functional modules, synthetic automation, system integration and improvement of radiochemical protection. In this review, research progress in microfluidic chip system for radio-synthesis of PET tracers has been summarized.

DISPLAY OPTIONS

Cite

Share

Cite

Share

Cite

Share

Cite

Share

Cite

Share

Cite

Share

Cite

Share

Cite

Share

Cite

Share

Cite

Share